Search filters

List of works by Anand Prakash Singh

A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation

scientific article published on 15 June 2020

A gp63 based vaccine candidate against Visceral Leishmaniasis

scientific article published on 22 January 2011

Acid-functionalized single-walled carbon nanotubes alter epithelial tight junctions and enhance paracellular permeability

scientific article published on 01 January 2020

Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis

scientific article published on 16 January 2019

Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload

scientific article published on 27 March 2019

Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

scientific article published on 2 February 2018

Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity

scientific article published on 30 April 2020

Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.

scientific article

Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation

scientific article published on 27 February 2018

Enteropathogenic E. coli: breaking the intestinal tight junction barrier

scientific article

Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.

scientific article published on 2 October 2015

Inhibition of GSK-3 to induce cardiomyocyte proliferation-a recipe for in situ cardiac regeneration

article

Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies

scientific article published on 01 April 2019

The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy

scientific article published on 10 October 2020